Skip to content

Circles

B

Brainstorm Cell Therapeutics Inc.

BCLI· OTC

B

BCLIBrainstorm Cell Therapeutics Inc.

BCLIBrainstorm Cell Therapeutics Inc.·Earnings record

Q2 2010

Filed Aug 16, 2010 · 10-Q · 47 days after period end · 0001144204-10-044848

Next · Q3 2010

Q2 2010 · 10-Q

Revenue—

Net Income

$614.00K

no prior Q2 2009 on file

EPS, diluted—

Same quarter

no prior Q2 2009 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Filing lag

ended Jun 30, 2010 · filed Aug 16, 2010 · 47 d after period end

Quarterly history

Q2 ’10Q3 ’10 Q4 ’10^d Q1 ’11 Q2 ’11 Q3 ’11 Q4 ’11^d Q1 ’12 Q2 ’12…

Brainstorm Cell Therapeutics Inc. · CIK 1137883 · Engraved from SEC EDGAR

Thaler ResearchEngraved from SEC EDGAR© 2026 Thaler. All rights reserved.Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Platform

Using AI API SDKs CLI

Research

News Listen Earnings Insiders Holders Compare Metrics

Screener Watchlists Pies Notes Your companies

Learn

Thaler

Thaler Agent Promise Provenance Circles Account Terms Privacy